STOCK TITAN

INOVIO to Report Third Quarter 2024 Financial Results on November 14, 2024

(Neutral)
(Neutral)
Tags
conferences earnings

INOVIO (NASDAQ: INO), a biotechnology company focused on DNA medicines for HPV-associated diseases, cancer, and infectious diseases, announced it will release its third quarter 2024 financial results after market close on November 14, 2024. The company will host a conference call and webcast at 4:30 p.m. ET on the same day, featuring a Q&A session with analysts. The webcast will be accessible at the company's investor relations website and will remain available for replay for 90 days.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – INO

+0.89%
+0.89% Session move

In the trading session that priced this news, INO gained 0.89%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

PLYMOUTH MEETING, Pa., Nov. 6, 2024 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer, and infectious diseases, today announced that third quarter 2024 financial results will be released after the market close on November 14, 2024. Following the release, INOVIO will host a live conference call and webcast at 4:30 p.m. ET to discuss financial results and provide a general business update.

The live webcast will be available online at http://ir.inovio.com/events-and-presentations/default.aspx. This is a listen-only event but will include a live Q&A with analysts. The webcast will be archived and available for replay for 90 days following the event.

About INOVIO
INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com.

Contacts
Media: Jennie Willson (267) 429-8567 jennie.willson@inovio.com
Investors: Thomas Hong (267) 440-4298 thomas.hong@inovio.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/inovio-to-report-third-quarter-2024-financial-results-on-november-14-2024-302297260.html

SOURCE INOVIO Pharmaceuticals, Inc.

FAQ

When will INOVIO (INO) release Q3 2024 earnings?

INOVIO will release its third quarter 2024 financial results after market close on November 14, 2024.

What time is INOVIO's (INO) Q3 2024 earnings call?

INOVIO's Q3 2024 earnings conference call and webcast will take place at 4:30 p.m. ET on November 14, 2024.

How long will INOVIO's (INO) Q3 2024 earnings webcast be available for replay?

The webcast will be archived and available for replay for 90 days following the event.